Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study82

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study31

Views

Views
May 20255
June 20251
July 202513
August 20254
September 20252
October 20252
November 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Brazil9
Finland2
Austria2
Colombia1
Germany1
Hong Kong1
Mexico1
Netherlands1
Peru1
 

Top cities views

Views
Vienna2
Turku2
Amsterdam1
Ankara1
Brooklyn1
Cabo Frio1
Cabo San Lucas1
Caxias do Sul1
Cotia1
Hamilton1